Protective Effects of a Red Orange and Lemon Extract (RLE) on the Hepatotoxicity Induced by Ochratoxin A in Rats
-
Published:2024-02-27
Issue:3
Volume:13
Page:289
-
ISSN:2076-3921
-
Container-title:Antioxidants
-
language:en
-
Short-container-title:Antioxidants
Author:
Longobardi Consiglia1ORCID, Damiano Sara1ORCID, Vaccaro Emanuela1, Ballistreri Gabriele2ORCID, Restucci Brunella1ORCID, Paciello Orlando1, Florio Salvatore1ORCID, Ciarcia Roberto1ORCID
Affiliation:
1. Veterinary Medicine and Animal Productions Department, University of Naples “Federico II”, 80137 Napoli, Italy 2. Council for Agricultural Research and Economics (CREA), Research Centre for Olive, Fruit and Citrus Crops, Corso Savoia, 190, 95024 Acireale, Italy
Abstract
Ochratoxin A (OTA) is a highly potent mycotoxin that contaminates many kinds of food and feed sources. Its significant impact on human health and animal productivity makes it a topic of particular concern. The role of specific bioactive compounds used as dietary antioxidants is believed to be substantial due to their capacity to act as free radical scavengers. Because of the well-known oxidative stress induced by OTA, the primary objective of this work was to evaluate the antioxidant effects of a standardized powder extract recovered from citrus processing waste, red orange and lemon extract (RLE), on liver damage induced by OTA in a rat model. This study aimed to examine the impact of oral administration of RLE (90 mg/kg b.w.) on hepatic function and oxidative balance in Sprague–Dawley rats (n = 6/group) treated with OTA (0.5 mg/kg b.w.) over a period of 14 days. The administration of OTA alone resulted in both biochemical changes and an imbalance in redox status in the liver. However, the use of RLE alleviated the activity of antioxidant enzymes and dramatically decreased the serum levels of ALT (alanine aminotransferase), AST (aspartate aminotransferase), and ALP (alkaline phosphatase), providing evidence of its protective benefits. Based on the findings from liver histology tests, the administration of RLE resulted in mitigation of lymphoplasmacytic inflammation, steatosis, and necrosis in the OTA group. These results indicate that the novel phytoextract RLE holds potential for application in the field of nutraceuticals.
Reference34 articles.
1. Ochratoxin A and human health risk: A review of the evidence;Wu;Crit. Rev. Food Sci. Nutr.,2015 2. Ochratoxin A: Occurrence and recent advances in detoxification;Wang;Toxicon,2022 3. EFSA Panel on Contaminants in the Food Chain (CONTAM), Schrenk, D., Bodin, L., Chipman, J.K., Del Mazo, J., Grasl-Kraupp, B., Hogstrand, C., Hoogenboom, L., Leblanc, J.-C., and Nebbia, C.S. (2020). Risk assessment of ochratoxin A in food. EFSA J., 18, e06113. 4. Khoi, C.-S., Chen, J.-H., Lin, T.-Y., Chiang, C.-K., and Hung, K.-Y. (2021). Ochratoxin A-Induced Nephrotoxicity: Up-to-Date Evidence. Int. J. Mol. Sci., 22. 5. Mutagenicity of Ochratoxin A: Role for a Carbon-Linked C8–Deoxyguanosine Adduct?;Manderville;J. Agric. Food Chem.,2017
|
|